BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1971297)

  • 1. Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice.
    Mathew RC; Ragheb S; Boros DL
    J Immunol; 1990 Jun; 144(11):4356-61. PubMed ID: 1971297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 influences IL-2 production and granulomatous inflammation in murine schistosomiasis mansoni.
    Yamashita T; Boros DL
    J Immunol; 1992 Dec; 149(11):3659-64. PubMed ID: 1431136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
    Yamashita T; Boros DL
    J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
    Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
    Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of granulomatous inflammation in murine schistosomiasis. V. Antigen-induced T cell-derived suppressor factors down-regulate proliferation and IL-2, but not IL-4, production by CD4+ effector T cells.
    Fidel PL; Boros DL
    J Immunol; 1991 Mar; 146(6):1941-8. PubMed ID: 1672335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.
    Cheever AW; Williams ME; Wynn TA; Finkelman FD; Seder RA; Cox TM; Hieny S; Caspar P; Sher A
    J Immunol; 1994 Jul; 153(2):753-9. PubMed ID: 8021510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production.
    Cheever AW; Finkelman FD; Caspar P; Heiny S; Macedonia JG; Sher A
    J Immunol; 1992 May; 148(10):3244-8. PubMed ID: 1533655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of granulomatous inflammation in murine schistosomiasis. IV. Antigen-induced suppressor T cells down-regulate proliferation and IL-2 production.
    Fidel PL; Boros DL
    J Immunol; 1990 Aug; 145(4):1257-64. PubMed ID: 2143210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 contributes to the IL-5 response in granulomas from mice infected with Schistosoma mansoni.
    Metwali A; Elliott D; Mathew R; Blum A; Weinstock JV
    J Immunol; 1993 Jan; 150(2):536-42. PubMed ID: 8419486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni.
    Pedras-Vasconcelos JA; Pearce EJ
    J Immunol; 1996 Oct; 157(7):3046-53. PubMed ID: 8816414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granuloma eosinophils enhance IL-5 production by lymphocytes from mice infected with Schistosoma mansoni.
    Metwali A; Elliott D; Blum AM; Weinstock JV
    J Immunol; 1993 Dec; 151(12):7048-56. PubMed ID: 8258709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
    Hernandez HJ; Wang Y; Stadecker MJ
    J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Ward JM; Cheever AW; Paul WE; Sher A
    J Immunol; 1999 Jul; 163(1):337-42. PubMed ID: 10384133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation.
    Joseph AL; Boros DL
    J Immunol; 1993 Nov; 151(10):5461-71. PubMed ID: 8228238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of granulomatous hypersensitivity. II. Participation of Ly 1+ and Ly 2+ T lymphocytes in the suppression of granuloma formation and lymphokine production in Schistosoma mansoni-infected mice.
    Chensue SW; Wellhausen SR; Boros DL
    J Immunol; 1981 Jul; 127(1):363-7. PubMed ID: 6972410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The granulomatous response in murine Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice.
    Metwali A; Elliott D; Blum AM; Li J; Sandor M; Lynch R; Noben-Trauth N; Weinstock JV
    J Immunol; 1996 Nov; 157(10):4546-53. PubMed ID: 8906833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice.
    Kullberg MC; Berzofsky JA; Jankovic DL; Barbieri S; Williams ME; Perlmann P; Sher A; Troye-Blomberg M
    J Immunol; 1996 Feb; 156(4):1482-9. PubMed ID: 8568251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance.
    Kelly EA; Colley DG
    J Immunol; 1988 Apr; 140(8):2737-45. PubMed ID: 3128606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role and effect of IL-2 in experimental visceral leishmaniasis.
    Murray HW; Miralles GD; Stoeckle MY; McDermott DF
    J Immunol; 1993 Jul; 151(2):929-38. PubMed ID: 8335921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice.
    Layland LE; Wagner H; da Costa CU
    Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.